Physician profile
Evan M Moore
NPI 1902240559
$4,483.54
in general payments reported to CMS, 2019-2025
13 companies · $2,732 in 2025
The $2,732 reported for 2025 was more than what 88% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $468 · 2021: $111 · 2022: $476 · 2023: $179 · 2024: $396 · 2025: $2,732.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,400 · Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,400.00 |
| Food and Beverage | $907.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $2,624.22 | 2024-2025 | |
| Sientra, INC. | $738.84 | 2020-2022 | |
| Davol INC. | $312.78 | 2022-2025 | Arista Ah Flexitip, Phasix Mesh |
| Allergan, INC. | $237.37 | 2019-2022 | |
| Baxter Healthcare | $132.25 | 2023 | Tisseel |
| Abbvie INC. | $117.35 | 2023-2025 | |
| Kci USA, INC. | $111.91 | 2020 | |
| Motiva USA, LLC | $84.98 | 2024-2025 | |
| Integra Lifesciences Corporation | $50.95 | 2024 | Integra, Omnigraft, Surgimend |
| Ethicon US, LLC | $23.50 | 2025 | Stratafix |
| W. L. Gore & Associates, INC. | $18.02 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Stryker Corporation | $15.88 | 2025 | Spy-Phi System |
| Solventum Corporation | $15.49 | 2024 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.